Publications

5674 Results

Carfilzomib, lenalidomide and dexamethasone (KRd) versus Bortezomib, lenalidomide and dexamethasone (VRd) for initial therapy of newly diagnosed multiple myeloma: results of ENDURANCE (E1A11) phase 3 trial

Authors
S Kumar;S Jacobus;A Cohen;M Weiss;N Callander;A Singh;T Parker;A Menter;A Yang;B Parsons;P Kumar;P Kappor;A Rosenberg;J Zonder;E Faber;S Lonial;P Richardson;R Orlowski;S Rajkumar
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr LBA3); American Society of Clinical Oncology Annual Meeting (5/29-6/2/20, Chicago, IL), oral, plenary
Year
2020
Research Committee(s)
Myeloma
Study Number(s)
CTSU/E1A11

A randomized Phase Ill trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo Stage IV breast cancer: a trial of the ECOG-ACRIN Research Group (E2108)

Authors
S Khan;F Zhao;L Solin;L Goldstein;D Cella;M Basik;M Golshan;T Julian;B Pockaj;C Lee;W Razaq;J Sparano;G Babiera;I Dy;S Jain;P Silverman;C Fisher;A Tevaarwerk;L Wagner;G Sledge
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr LBA2); American Society of Clinical Oncology Annual Meeting (5/29-6/2/20, Chicago, IL), oral, plenary
Year
2020
Research Committee(s)
Breast
Study Number(s)
CTSU/E2108

Patient-reported outcomes among patients with resected high-risk melanoma (AJCC7 1118, IIIC, Mla, Mlb) randomized to low- or high-dose adjuvant lpilimumab (ipi) versus high­dose interferon alfa-2b {HDI): Health-related quality of life {HRQL) analysis of ECOG-ACRIN E1609

Authors
A Tarhini;Y Zheng;S Lee;F Hodi;U Rao;G Cohen;V Sondak;J Kirkwood;L Wagner
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr e22078); American Society of Clinical Oncology Annual Meeting (5/29-6/2/20, Chicago, IL), publication only
Year
2020
Research Committee(s)
Melanoma
Study Number(s)
CTSU/E1609

Unknown primary tumor high-risk melanoma as a unique patient population with distinct prognosis in the adjuvant setting: An ECOG-ACRIN E1609 study analysis

Authors
A Tarhini;S Lee;S Hodi;G Cohen;U Rao;V Sondak;J Kirkwood
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr e22090); American Society of Clinical Oncology Annual Meeting (5/29-6/2/20, Chicago, IL), publication only
Year
2020
Research Committee(s)
Melanoma
Study Number(s)
CTSU/E1609

ALLIANCE A151804: Establishment of a National Biorepository to Advance Studies of Immune-related Adverse Events

Authors
D Kozono;E Sharon;J Le-Rademacher;E Twohy;T Zemla;Y Wen;M Watson;E Dib;J Kirkwood;G Lyman;L Naidoo;A Nixon;E Mittendorf
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr TPS3154); American Society of Clinical Oncology 2020 Annual Meeting, poster
Year
2020
Study Number(s)
CTSU/A151804

Relevance of bone marrow biopsies for response assessment in NCTN follicular lymphoma clinical trials

Authors
S Rutherford;J Yin;L Pederson;B LaPlant;M Shadman;H Li;M LeBlanc;K Blum;T Dockter;P Martin;S Jung;B Grant;C Rosenbaum;C Ujjani;P Barr;J Unger;N Bartlett;JW Friedberg;J Leonard
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 8038); American Society of Clinical Oncology 2020 Annual Meeting, poster
Year
2020
Research Committee(s)
Lymphoma
Study Number(s)
S0016, S0801

A Randomized Phase II Study of MLN0128 (M) vs. Pazopanib (P) in Pts with Advanced Sarcoma (Alliance A091304)

Authors
M Ingham;M Mahoney;S D'Angelo;M Dickson;S Attia;J Crawford;A Elias;D Liebner;M Agulnik;K Thornton;V Monga;G Schartz;W Tap
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 11562); American Society of Clinical Oncology 2020 Annual Meeting, poster
Year
2020

Rural and urban disparities based on zip code of residence: Analyses of 834 and 2159 patients in N9741 and CALGB 80405 trials respectively.

Authors
M Malla;L Huebner;S Piawah;H-J Lenz;J Meyerhardt;E O'Reilly;CD Blanke;Q Shi;A Venook;R Goldberg
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr e16076); American Society of Clinical Oncology 2020 Annual Meeting, publication only
Year
2020
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405, N9741

Predictive and prognostic value of HER2 gene expression and HER2 amplification in patients with metastatic colorectal cancer (mCRC) enrolled in CALGB/SWOG 80405 (Alliance)

Authors
F Battaglin;F-S Ou;Z Qu;M Bertagnolli;H Hochster;D Niedzwiecki;R Goldberg;R Mayer;T Zemla;CD Blanke;A Venook;C Bias;O Kabbarah;H-J Lenz;F Innocenti
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 4086); American Society of Clinical Oncology 2020 Annual Meeting, poster
Year
2020
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Improved clinical outcomes in patients with BRAFV600 mutant melanoma and undetectable circulating tumor DNA treated with dabrafenib and trametinib

Authors
A Algazi;M Othus;B Voorhies;K Kendra;S Dakhil;A Harker-Murray;C Lao;B Chmielowski;R Lo;K Grossmann;A Ribas
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 10059); American Society of Clinical Oncology 2020 Annual Meeting, poster
Year
2020
Research Committee(s)
Melanoma
Study Number(s)
S1320